MUPIROCIN CALCIUM

MUPIROCIN CALCIUM was reported 14135 times

MUPIROCIN CALCIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 168 0.5545
1 NASAL VESTIBULITIS 17 0.1700
2 PURPURA SENILE 13 0.1066
3 BURKHOLDERIA TEST POSITIVE 13 0.1048
4 FEMALE GENITAL TRACT FISTULA 177 0.1036
5 MACULAR DEGENERATION 821 0.0687
6 RADICULOPATHY 179 0.0679
7 CHRONIC SINUSITIS 233 0.0620
8 PROCTITIS 169 0.0603
9 MATERNAL CONDITION AFFECTING FOETUS 12 0.0543
10 TARSAL TUNNEL SYNDROME 11 0.0500
11 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 48 0.0452
12 HUMIDITY INTOLERANCE 18 0.0450
13 TERATOGENICITY 12 0.0397
14 INTERCEPTED PRODUCT PRESCRIBING ERROR 42 0.0317
15 HYPERPARATHYROIDISM SECONDARY 72 0.0287
16 NEPHROGENIC ANAEMIA 123 0.0265
17 LENTIGO 10 0.0202
18 SEBORRHOEIC KERATOSIS 29 0.0200
19 REBOUND ACID HYPERSECRETION 57 0.0188
20 FOLATE DEFICIENCY 20 0.0173
21 VAGINAL DISCHARGE 170 0.0168
22 NASAL DISCHARGE DISCOLOURATION 23 0.0167
23 PARAESTHESIA ORAL 233 0.0161
24 IMPETIGO 23 0.0154
25 CLEFT LIP AND PALATE 17 0.0152
26 RESORPTION BONE INCREASED 12 0.0146
27 ORAL CANDIDIASIS 189 0.0143
28 BONE DEMINERALISATION 15 0.0142
29 BODY TEMPERATURE ABNORMAL 25 0.0136
30 TRACHEITIS 10 0.0131
31 SKIN WEEPING 45 0.0126
32 CUTANEOUS T-CELL LYMPHOMA 14 0.0111
33 GROIN ABSCESS 13 0.0110
34 INFUSION SITE DISCHARGE 19 0.0108
35 END STAGE RENAL DISEASE 186 0.0102
36 RHINALGIA 28 0.0102
37 INFUSION SITE BRUISING 22 0.0102
38 INFUSION SITE MASS 11 0.0101
39 ANAEMIA OF CHRONIC DISEASE 9 0.0100
40 ASPERGILLOSIS 13 0.0099
41 TOOTH EROSION 12 0.0098
42 STAPHYLOCOCCAL SKIN INFECTION 12 0.0098
43 LUMBAR RADICULOPATHY 11 0.0095
44 PERIRECTAL ABSCESS 10 0.0090
45 VESTIBULAR DISORDER 11 0.0090
46 XEROSIS 11 0.0089
47 LINEAR IGA DISEASE 14 0.0084
48 SINUS OPERATION 20 0.0084
49 FOOD AVERSION 14 0.0082
50 PROCEDURAL PAIN 225 0.0081
51 SEBORRHOEIC DERMATITIS 13 0.0079
52 CHRONIC KIDNEY DISEASE 586 0.0077
53 INFUSION SITE PRURITUS 24 0.0076
54 PRODUCT PRESCRIBING ISSUE 162 0.0074
55 SKIN INFECTION 81 0.0072
56 FREQUENT BOWEL MOVEMENTS 193 0.0071
57 PUSTULE 16 0.0067
58 NASAL SEPTUM DEVIATION 13 0.0066
59 ESSENTIAL HYPERTENSION 12 0.0066
60 SKIN WOUND 11 0.0065
61 VERTIGO POSITIONAL 11 0.0063
62 DERMAL CYST 15 0.0061
63 RECALLED PRODUCT ADMINISTERED 57 0.0060
64 INGROWING NAIL 14 0.0059
65 NEURODERMATITIS 22 0.0059
66 COLITIS 218 0.0057
67 CHEILITIS 30 0.0055
68 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 93 0.0054
69 HORDEOLUM 23 0.0053
70 THROMBOPHLEBITIS SUPERFICIAL 16 0.0053
71 PAPULE 37 0.0052
72 APPLICATION SITE PAIN 115 0.0052
73 STAPHYLOCOCCAL INFECTION 171 0.0052
74 SEASONAL ALLERGY 73 0.0052
75 MULTIPLE ALLERGIES 40 0.0051
76 RECTAL HAEMORRHAGE 219 0.0051
77 SKIN ABRASION 24 0.0051
78 SKIN HAEMORRHAGE 75 0.0051
79 PARANASAL SINUS DISCOMFORT 19 0.0050
80 MELANOCYTIC NAEVUS 22 0.0050
81 SKIN FISSURES 98 0.0050
82 ACTINIC KERATOSIS 13 0.0050
83 CLOSTRIDIUM TEST POSITIVE 11 0.0050
84 ANHEDONIA 131 0.0050
85 WOUND COMPLICATION 17 0.0049
86 EYELID PAIN 10 0.0049
87 DEVICE INFUSION ISSUE 12 0.0048
88 SCAB 55 0.0048
89 SKIN DISCOMFORT 13 0.0048
90 ECONOMIC PROBLEM 73 0.0048
91 SQUAMOUS CELL CARCINOMA OF SKIN 29 0.0048
92 NASAL DISCOMFORT 37 0.0047
93 BLOOD CHLORIDE DECREASED 12 0.0046
94 DERMATITIS ATOPIC 244 0.0046
95 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 25 0.0046
96 PARONYCHIA 20 0.0045
97 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 323 0.0045
98 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 77 0.0045
99 BLOOD IMMUNOGLOBULIN G DECREASED 11 0.0044
100 COLITIS ULCERATIVE 198 0.0044
101 SUBCUTANEOUS ABSCESS 21 0.0044
102 PRODUCT PHYSICAL CONSISTENCY ISSUE 24 0.0043
103 RENAL TUBULAR NECROSIS 42 0.0043
104 INFUSION SITE HAEMORRHAGE 14 0.0043
105 OSTEOPENIA 64 0.0042
106 TUBULOINTERSTITIAL NEPHRITIS 79 0.0042
107 PRODUCT ADMINISTRATION INTERRUPTED 33 0.0042
108 PLANTAR FASCIITIS 14 0.0042
109 HIDRADENITIS 38 0.0042
110 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
111 WOUND SECRETION 16 0.0041
112 ARTHROPOD BITE 30 0.0040
113 SKIN EROSION 13 0.0040
114 INFUSION SITE ERYTHEMA 34 0.0040
115 UPPER-AIRWAY COUGH SYNDROME 33 0.0040
116 MACULE 11 0.0040
117 SKIN LACERATION 43 0.0040
118 SCRATCH 41 0.0039
119 PRE-EXISTING CONDITION IMPROVED 24 0.0038
120 HAEMATOCHEZIA 209 0.0038
121 DERMATITIS CONTACT 43 0.0038
122 ABSCESS LIMB 16 0.0038
123 ANIMAL BITE 10 0.0037
124 CONCUSSION 29 0.0037
125 INFUSION RELATED REACTION 245 0.0037
126 NECROTISING FASCIITIS 13 0.0037
127 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 67 0.0037
128 PRODUCT USE IN UNAPPROVED INDICATION 906 0.0037
129 EAR PAIN 71 0.0036
130 SKIN LESION 99 0.0036
131 RHINOVIRUS INFECTION 14 0.0036
132 DERMATITIS 75 0.0036
133 BLOOD BLISTER 11 0.0035
134 ODYNOPHAGIA 21 0.0035
135 PURULENT DISCHARGE 15 0.0035
136 NASAL DRYNESS 22 0.0035
137 INFUSION SITE SWELLING 22 0.0035
138 RENAL FAILURE 459 0.0035
139 SNORING 13 0.0034
140 APPLICATION SITE SWELLING 17 0.0034
141 NECK INJURY 10 0.0034
142 PARANASAL SINUS HYPERSECRETION 13 0.0034
143 RENAL INJURY 101 0.0034
144 SKIN ULCER 87 0.0034
145 TENDERNESS 35 0.0034
146 LOCALISED INFECTION 81 0.0033
147 SPINAL OSTEOARTHRITIS 29 0.0033
148 APPLICATION SITE HAEMORRHAGE 9 0.0033
149 CELLULITIS 166 0.0033
150 FURUNCLE 26 0.0033
151 SECRETION DISCHARGE 41 0.0033
152 STAPHYLOCOCCAL SEPSIS 16 0.0032
153 PHARYNGITIS STREPTOCOCCAL 35 0.0032
154 HYPERCHLORHYDRIA 19 0.0032
155 FUNGAL SKIN INFECTION 13 0.0032
156 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 93 0.0032
157 LIGAMENT SPRAIN 31 0.0031
158 BLOOD URIC ACID INCREASED 18 0.0031
159 HYPOPHOSPHATAEMIA 23 0.0031
160 SKIN SWELLING 27 0.0031
161 INFUSION SITE PAIN 40 0.0031
162 ACCIDENT 37 0.0031
163 SKIN WARM 18 0.0031
164 SINUS DISORDER 61 0.0031
165 PIGMENTATION DISORDER 19 0.0031
166 INSURANCE ISSUE 47 0.0031
167 DYSPEPSIA 300 0.0030
168 SYNOVIAL CYST 14 0.0030
169 PSEUDOMONAS INFECTION 26 0.0030
170 ACUTE RESPIRATORY FAILURE 58 0.0030
171 EAR INFECTION 80 0.0030
172 ECZEMA 157 0.0030
173 SQUAMOUS CELL CARCINOMA 28 0.0030
174 CONJUNCTIVITIS 55 0.0030
175 MUSCLE DISORDER 24 0.0030
176 SINUSITIS 302 0.0029
177 PERIPHERAL VENOUS DISEASE 12 0.0029
178 INCORRECT ROUTE OF DRUG ADMINISTRATION 105 0.0029
179 ENTEROCOCCAL INFECTION 14 0.0029
180 SINUS CONGESTION 39 0.0029
181 ACUTE KIDNEY INJURY 440 0.0029
182 VASCULAR DEVICE INFECTION 13 0.0029
183 SCAR 49 0.0029
184 THERAPEUTIC PRODUCT EFFECT DELAYED 13 0.0028
185 HYPERVOLAEMIA 14 0.0028
186 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
187 EXERCISE TOLERANCE DECREASED 16 0.0028
188 UPPER RESPIRATORY TRACT INFECTION 127 0.0027
189 EYE INFECTION 31 0.0027
190 LIMB INJURY 74 0.0027
191 APPLICATION SITE DISCOLOURATION 11 0.0027
192 RHINITIS ALLERGIC 12 0.0027
193 VITAMIN D DEFICIENCY 26 0.0027
194 BLOOD MAGNESIUM DECREASED 23 0.0027
195 SPINAL STENOSIS 11 0.0027
196 TOXIC EPIDERMAL NECROLYSIS 40 0.0026
197 DIABETIC NEUROPATHY 13 0.0026
198 ATTENTION DEFICIT HYPERACTIVITY DISORDER 11 0.0026
199 BACTERAEMIA 31 0.0026
200 THYROID MASS 10 0.0026
201 MAJOR DEPRESSION 19 0.0026
202 INTERCEPTED MEDICATION ERROR 12 0.0026
203 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
204 SCOLIOSIS 16 0.0026
205 DECUBITUS ULCER 21 0.0026
206 ROSACEA 12 0.0026
207 APPETITE DISORDER 17 0.0026
208 DRUG ADMINISTERED AT INAPPROPRIATE SITE 27 0.0026
209 SKIN EXFOLIATION 216 0.0026
210 ESCHERICHIA INFECTION 21 0.0026
211 GASTROENTERITIS VIRAL 46 0.0025
212 PROSTATOMEGALY 10 0.0025
213 HAND FRACTURE 18 0.0025
214 HYPERKERATOSIS 14 0.0025
215 PERIPHERAL VASCULAR DISORDER 13 0.0025
216 ABSCESS 40 0.0025
217 AZOTAEMIA 10 0.0025
218 SKIN PLAQUE 21 0.0025
219 ATELECTASIS 24 0.0025
220 WOUND 69 0.0025
221 TOOTH ABSCESS 25 0.0025
222 SNEEZING 55 0.0024
223 ANAL INCONTINENCE 22 0.0024
224 HEPARIN-INDUCED THROMBOCYTOPENIA 12 0.0024
225 IMPAIRED GASTRIC EMPTYING 33 0.0024
226 INFUSION SITE EXTRAVASATION 15 0.0024
227 PRODUCT PRESCRIBING ERROR 57 0.0024
228 BREAST MASS 16 0.0024
229 AUTOIMMUNE THYROIDITIS 9 0.0024
230 EPISTAXIS 178 0.0024
231 SKIN CANCER 51 0.0024
232 ORAL HERPES 46 0.0024
233 PHLEBITIS 12 0.0023
234 GASTROINTESTINAL INFECTION 21 0.0023
235 RESPIRATORY TRACT INFECTION 61 0.0023
236 RENAL FAILURE CHRONIC 18 0.0023
237 POST PROCEDURAL INFECTION 19 0.0023
238 HOSPICE CARE 23 0.0023
239 ONYCHOMYCOSIS 10 0.0023
240 IRON DEFICIENCY ANAEMIA 21 0.0023
241 SKIN ATROPHY 13 0.0023
242 BASAL CELL CARCINOMA 35 0.0022
243 POST-TRAUMATIC STRESS DISORDER 15 0.0022
244 MALNUTRITION 25 0.0022
245 SWELLING OF EYELID 14 0.0022
246 FOOT FRACTURE 42 0.0022
247 RHINORRHOEA 143 0.0022
248 SLEEP APNOEA SYNDROME 42 0.0022
249 TOOTH INFECTION 29 0.0022
250 BLISTER 123 0.0022
251 LUMBAR VERTEBRAL FRACTURE 10 0.0022
252 INCREASED TENDENCY TO BRUISE 20 0.0022
253 GROIN PAIN 19 0.0022
254 GANGRENE 13 0.0022
255 ARTHRITIS INFECTIVE 10 0.0022
256 HEART RATE ABNORMAL 12 0.0021
257 NEPHROPATHY 20 0.0021
258 KIDNEY INFECTION 42 0.0021
259 RIB FRACTURE 44 0.0021
260 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
261 PEMPHIGOID 16 0.0021
262 FAILURE TO THRIVE 11 0.0021
263 ARTERIOSCLEROSIS CORONARY ARTERY 14 0.0021
264 WEIGHT DECREASED 588 0.0021
265 WOUND INFECTION 23 0.0021
266 OSTEOARTHRITIS 89 0.0021
267 SKIN DISORDER 70 0.0021
268 SKIN MASS 14 0.0021
269 NASAL CONGESTION 123 0.0021
270 BACTERIAL INFECTION 39 0.0021
271 ERYTHEMA 428 0.0021
272 PAIN OF SKIN 56 0.0021
273 MOUTH SWELLING 12 0.0021
274 DENTAL CARIES 23 0.0021
275 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
276 BONE DENSITY DECREASED 65 0.0021
277 POSTOPERATIVE WOUND INFECTION 14 0.0021
278 DYSPNOEA EXERTIONAL 78 0.0021
279 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
280 PRODUCT USE ISSUE 387 0.0021
281 BRONCHITIS 152 0.0021
282 HYPOVOLAEMIA 12 0.0020
283 ORAL DISORDER 15 0.0020
284 MOUTH HAEMORRHAGE 15 0.0020
285 PHARYNGEAL SWELLING 20 0.0020
286 FOREIGN BODY SENSATION IN EYES 13 0.0020
287 FACIAL PAIN 18 0.0020
288 CYST 25 0.0020
289 PULMONARY MASS 30 0.0020
290 PRODUCTIVE COUGH 96 0.0020
291 ANAEMIA 383 0.0020
292 HYPERNATRAEMIA 10 0.0020
293 OSTEOPOROSIS 82 0.0020
294 CYSTIC FIBROSIS 11 0.0020
295 SKIN DISCOLOURATION 91 0.0020
296 BRAIN FOG 31 0.0020
297 PRODUCT DOSE OMISSION IN ERROR 56 0.0020
298 KLEBSIELLA INFECTION 10 0.0020
299 THERMAL BURN 14 0.0020
300 FOOD ALLERGY 15 0.0019
301 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
302 BLOOD IRON DECREASED 23 0.0019
303 DRY SKIN 258 0.0019
304 POOR VENOUS ACCESS 20 0.0019
305 KNEE OPERATION 19 0.0019
306 FLUID OVERLOAD 28 0.0019
307 DRY EYE 96 0.0019
308 RASH PUSTULAR 14 0.0019
309 WRIST FRACTURE 23 0.0019
310 GASTROOESOPHAGEAL REFLUX DISEASE 154 0.0019
311 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 13 0.0019
312 SENSITIVE SKIN 14 0.0019
313 NECK PAIN 106 0.0019
314 GOUT 34 0.0019
315 RESPIRATORY TRACT CONGESTION 30 0.0019
316 CONSTIPATION 410 0.0019
317 ORAL PAIN 42 0.0019
318 VITAMIN D DECREASED 16 0.0019
319 PATHOGEN RESISTANCE 17 0.0019
320 COVID-19 PNEUMONIA 22 0.0019
321 BLOOD POTASSIUM DECREASED 56 0.0019
322 RHINITIS 15 0.0019
323 FUNGAL INFECTION 62 0.0019
324 ANAL ABSCESS 10 0.0019
325 APPLICATION SITE PRURITUS 42 0.0018
326 HERPES SIMPLEX 12 0.0018
327 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
328 CANDIDA INFECTION 31 0.0018
329 ABNORMAL FAECES 15 0.0018
330 OSTEOMYELITIS 33 0.0018
331 ABDOMINAL TENDERNESS 9 0.0018
332 PHOTOPHOBIA 34 0.0018
333 HYPOALBUMINAEMIA 14 0.0018
334 STREPTOCOCCAL INFECTION 10 0.0018
335 SPUTUM DISCOLOURED 17 0.0018
336 MENISCUS INJURY 11 0.0018
337 BRONCHIECTASIS 12 0.0018
338 HERPES ZOSTER 102 0.0018
339 PERIORBITAL SWELLING 10 0.0018
340 TOOTHACHE 32 0.0018
341 CHOLECYSTITIS ACUTE 10 0.0018
342 HIP ARTHROPLASTY 27 0.0018
343 ATRIAL FLUTTER 14 0.0018
344 DIZZINESS POSTURAL 17 0.0018
345 ECCHYMOSIS 12 0.0017
346 ILLNESS 180 0.0017
347 IMMUNE SYSTEM DISORDER 23 0.0017
348 AUTOIMMUNE DISORDER 17 0.0017
349 ONYCHOCLASIS 12 0.0017
350 HERPES VIRUS INFECTION 10 0.0017
351 LYMPHOEDEMA 12 0.0017
352 EYE DISCHARGE 18 0.0017
353 THERAPY PARTIAL RESPONDER 27 0.0017
354 PRODUCT DISTRIBUTION ISSUE 16 0.0017
355 TRANSFUSION 18 0.0017
356 APPLICATION SITE ERYTHEMA 45 0.0017
357 VASCULITIS 20 0.0017
358 ABDOMINAL PAIN 398 0.0017
359 FLANK PAIN 16 0.0017
360 RASH PRURITIC 92 0.0017
361 HYPOPHAGIA 43 0.0017
362 HYPERLIPIDAEMIA 20 0.0017
363 PELVIC FRACTURE 13 0.0017
364 DECREASED ACTIVITY 18 0.0017
365 PERIPHERAL SWELLING 257 0.0017
366 VIRAL INFECTION 55 0.0017
367 CARDIAC FAILURE ACUTE 11 0.0016
368 PRURITUS 633 0.0016
369 INGUINAL HERNIA 10 0.0016
370 SLEEP DISORDER 116 0.0016
371 CHOLECYSTITIS CHRONIC 11 0.0016
372 CARPAL TUNNEL SYNDROME 23 0.0016
373 EYE PRURITUS 55 0.0016
374 URINARY TRACT INFECTION 279 0.0016
375 ROTATOR CUFF SYNDROME 21 0.0016
376 RASH MACULAR 57 0.0016
377 SPINAL OPERATION 20 0.0016
378 HIATUS HERNIA 21 0.0016
379 HYPOXIA 57 0.0016
380 CARDIAC MURMUR 14 0.0016
381 GENERALISED OEDEMA 20 0.0016
382 ANKLE FRACTURE 25 0.0016
383 INTENTIONAL DOSE OMISSION 46 0.0016
384 BLOOD UREA INCREASED 27 0.0016
385 HEAD INJURY 51 0.0016
386 PYREXIA 555 0.0016
387 IMPAIRED QUALITY OF LIFE 23 0.0016
388 NEPHROLITHIASIS 73 0.0016
389 MULTIPLE INJURIES 10 0.0016
390 PULMONARY HYPERTENSION 33 0.0016
391 CHOLECYSTECTOMY 18 0.0016
392 SURGERY 92 0.0016
393 BURSITIS 19 0.0016
394 MUCOSAL INFLAMMATION 41 0.0016
395 BIPOLAR DISORDER 17 0.0016
396 CONTUSION 150 0.0016
397 DYSPHONIA 91 0.0016
398 PROCTALGIA 10 0.0016
399 OEDEMA 84 0.0015
400 DIVERTICULUM 11 0.0015
401 JOINT INJURY 33 0.0015
402 PAIN 948 0.0015
403 TOOTH FRACTURE 17 0.0015
404 FEAR OF INJECTION 11 0.0015
405 DYSSTASIA 45 0.0015
406 PSORIASIS 201 0.0015
407 CYSTITIS 49 0.0015
408 THROAT IRRITATION 69 0.0015
409 OXYGEN SATURATION DECREASED 86 0.0015
410 BURNING SENSATION 107 0.0015
411 FOLLICULITIS 16 0.0015
412 RENAL CYST 12 0.0015
413 TRICUSPID VALVE INCOMPETENCE 12 0.0015
414 MITRAL VALVE INCOMPETENCE 17 0.0015
415 WHEEZING 89 0.0015
416 INJECTION SITE IRRITATION 19 0.0015
417 OROPHARYNGEAL PAIN 138 0.0015
418 URINE OUTPUT DECREASED 13 0.0015
419 NAIL DISORDER 13 0.0015
420 BONE DISORDER 27 0.0015
421 NEURALGIA 36 0.0015
422 TASTE DISORDER 30 0.0015
423 BACK DISORDER 24 0.0015
424 SUNBURN 11 0.0015
425 EMOTIONAL DISTRESS 178 0.0015
426 EXPOSURE VIA SKIN CONTACT 38 0.0015
427 RESPIRATORY RATE INCREASED 13 0.0015
428 CARDIOMEGALY 18 0.0015
429 IMPAIRED HEALING 48 0.0015
430 DISCOMFORT 89 0.0015
431 PAROSMIA 11 0.0015
432 RASH 635 0.0015
433 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 76 0.0015
434 FLUID RETENTION 74 0.0015
435 PULMONARY ARTERIAL HYPERTENSION 21 0.0014
436 SCIATICA 23 0.0014
437 PNEUMONIA 467 0.0014
438 NEUROPATHY PERIPHERAL 137 0.0014
439 GASTROENTERITIS 21 0.0014
440 INFECTION 208 0.0014
441 COUGH 403 0.0014
442 MATERNAL DRUGS AFFECTING FOETUS 11 0.0014
443 ROAD TRAFFIC ACCIDENT 60 0.0014
444 BLOOD SODIUM DECREASED 27 0.0014
445 PRODUCT DOSE OMISSION ISSUE 420 0.0014
446 NIGHT SWEATS 46 0.0014
447 ENCEPHALOPATHY 35 0.0014
448 INCONTINENCE 15 0.0014
449 QUALITY OF LIFE DECREASED 19 0.0014
450 MIGRAINE 135 0.0014
451 COVID-19 248 0.0014
452 HAEMATOCRIT DECREASED 28 0.0014
453 UROSEPSIS 13 0.0014
454 PSORIATIC ARTHROPATHY 57 0.0014
455 ANXIETY 399 0.0014
456 ADRENAL INSUFFICIENCY 17 0.0014
457 INTERNAL HAEMORRHAGE 16 0.0014
458 IRRITABLE BOWEL SYNDROME 30 0.0014
459 CARDIAC OPERATION 12 0.0014
460 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 67 0.0014
461 CONDITION AGGRAVATED 424 0.0014
462 MUSCULOSKELETAL DISCOMFORT 24 0.0014
463 PSYCHOLOGICAL TRAUMA 12 0.0014
464 PERITONITIS BACTERIAL 14 0.0014
465 BLOOD ALBUMIN DECREASED 11 0.0014
466 STOMATITIS 84 0.0014
467 EYE PAIN 78 0.0014
468 LEUKOCYTOSIS 25 0.0014
469 DERMATITIS BULLOUS 10 0.0014
470 SEPSIS 154 0.0014
471 BACK INJURY 15 0.0014
472 NODULE 18 0.0014
473 OCULAR HYPERAEMIA 65 0.0014
474 APPLICATION SITE IRRITATION 17 0.0014
475 INFLUENZA 152 0.0014
476 PRODUCT COMMUNICATION ISSUE 12 0.0014
477 RASH ERYTHEMATOUS 65 0.0014
478 SEPTIC SHOCK 59 0.0014
479 EYE IRRITATION 78 0.0014
480 LOWER LIMB FRACTURE 26 0.0014
481 DRUG PRESCRIBING ERROR 26 0.0014
482 CEREBRAL DISORDER 10 0.0014
483 TOOTH DISORDER 30 0.0013
484 NERVE INJURY 15 0.0013
485 HYPERCHOLESTEROLAEMIA 13 0.0013
486 MALIGNANT MELANOMA 18 0.0013
487 WEIGHT FLUCTUATION 14 0.0013
488 OEDEMA PERIPHERAL 163 0.0013
489 HYDRONEPHROSIS 10 0.0013
490 JOINT STIFFNESS 35 0.0013
491 WHITE BLOOD CELL COUNT INCREASED 51 0.0013
492 BLOOD ALKALINE PHOSPHATASE INCREASED 33 0.0013
493 CLOSTRIDIUM DIFFICILE INFECTION 29 0.0013
494 THERAPEUTIC RESPONSE SHORTENED 44 0.0013
495 LIP DRY 12 0.0013
496 FIBROMYALGIA 32 0.0013
497 EATING DISORDER 28 0.0013
498 TROPONIN INCREASED 10 0.0013
499 EXOSTOSIS 12 0.0013
500 HYPERKALAEMIA 46 0.0013
501 ASTHMA 148 0.0013
502 BODY HEIGHT DECREASED 14 0.0013
503 GLAUCOMA 25 0.0013
504 APHTHOUS ULCER 10 0.0013
505 MASS 18 0.0013
506 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
507 SARS-COV-2 TEST POSITIVE 17 0.0013
508 CARDIOMYOPATHY 19 0.0013
509 SKIN HYPERPIGMENTATION 11 0.0013
510 MULTIPLE FRACTURES 21 0.0013
511 MUSCLE STRAIN 11 0.0013
512 SPINAL DISORDER 12 0.0013
513 EAR DISCOMFORT 13 0.0013
514 BLOOD URINE PRESENT 24 0.0013
515 EXPIRED PRODUCT ADMINISTERED 42 0.0013
516 MUSCLE ATROPHY 16 0.0013
517 PRODUCT PACKAGING ISSUE 12 0.0013
518 RED BLOOD CELL COUNT DECREASED 36 0.0013
519 DECREASED APPETITE 292 0.0013
520 ULCER 20 0.0013
521 HYPERSOMNIA 36 0.0013
522 OBESITY 20 0.0013
523 HEADACHE 787 0.0013
524 CORONARY ARTERY DISEASE 38 0.0013
525 POOR QUALITY SLEEP 27 0.0013
526 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 226 0.0013
527 SWELLING 117 0.0012
528 SPINAL FRACTURE 25 0.0012
529 OCULAR DISCOMFORT 14 0.0012
530 POLLAKIURIA 52 0.0012
531 FISTULA 14 0.0012
532 GINGIVAL BLEEDING 17 0.0012
533 BLOOD CALCIUM DECREASED 14 0.0012
534 PNEUMONIA ASPIRATION 31 0.0012
535 NAUSEA 973 0.0012
536 MUSCULOSKELETAL CHEST PAIN 19 0.0012
537 GAIT INABILITY 41 0.0012
538 LACRIMATION INCREASED 37 0.0012
539 MENTAL STATUS CHANGES 34 0.0012
540 LETHARGY 70 0.0012
541 RESTLESS LEGS SYNDROME 22 0.0012
542 PHARYNGITIS 15 0.0012
543 DRUG INEFFECTIVE 1593 0.0012
544 ILEUS 15 0.0012
545 TOOTH LOSS 25 0.0012
546 ELECTROLYTE IMBALANCE 14 0.0012
547 PNEUMONIA BACTERIAL 11 0.0012
548 POST PROCEDURAL COMPLICATION 23 0.0012
549 SINUS TACHYCARDIA 17 0.0012
550 MALAISE 525 0.0012
551 BLOOD THYROID STIMULATING HORMONE INCREASED 11 0.0012
552 ARTHRITIS 94 0.0012
553 OESOPHAGITIS 13 0.0012
554 FALL 395 0.0012
555 HAEMOPTYSIS 33 0.0012
556 EYE SWELLING 44 0.0012
557 ATRIAL FIBRILLATION 115 0.0012
558 PRODUCT DOSE OMISSION 77 0.0012
559 BLOOD CREATININE INCREASED 77 0.0012
560 RESPIRATORY FAILURE 86 0.0012
561 GALLBLADDER DISORDER 21 0.0012
562 COMPLICATION ASSOCIATED WITH DEVICE 17 0.0012
563 LACERATION 11 0.0012
564 DEVICE RELATED INFECTION 18 0.0012
565 ARTERIOSCLEROSIS 11 0.0012
566 UNEVALUABLE EVENT 88 0.0012
567 BACK PAIN 270 0.0012
568 RASH PAPULAR 26 0.0012
569 RESPIRATORY DISTRESS 32 0.0012
570 SKIN IRRITATION 53 0.0012
571 DEPRESSION 263 0.0012
572 DIVERTICULITIS 32 0.0012
573 PYELONEPHRITIS 10 0.0012
574 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
575 OFF LABEL USE 1004 0.0011
576 BLOOD PRESSURE INCREASED 175 0.0011
577 INTERVERTEBRAL DISC PROTRUSION 25 0.0011
578 CYTOPENIA 14 0.0011
579 IMMUNODEFICIENCY 17 0.0011
580 COAGULOPATHY 19 0.0011
581 MOUTH ULCERATION 24 0.0011
582 RESPIRATORY DISORDER 34 0.0011
583 LIMB DISCOMFORT 35 0.0011
584 FEBRILE NEUTROPENIA 75 0.0011
585 HAEMORRHOIDS 22 0.0011
586 TOOTH EXTRACTION 14 0.0011
587 DIARRHOEA 722 0.0011
588 HEREDITARY ANGIOEDEMA 12 0.0011
589 PLEURAL EFFUSION 68 0.0011
590 DEHYDRATION 149 0.0011
591 CARDIOGENIC SHOCK 16 0.0011
592 DERMATITIS ALLERGIC 14 0.0011
593 FLATULENCE 63 0.0011
594 SPINAL PAIN 13 0.0011
595 OROPHARYNGEAL DISCOMFORT 10 0.0011
596 RENAL IMPAIRMENT 93 0.0011
597 BLOOD PRESSURE ABNORMAL 22 0.0011
598 HYPOKALAEMIA 51 0.0011
599 INFLAMMATION 57 0.0011
600 GASTRITIS 29 0.0011
601 ARTHRALGIA 458 0.0011
602 PULMONARY THROMBOSIS 12 0.0011
603 HEART RATE INCREASED 109 0.0011
604 ASPIRATION 12 0.0011
605 CARDIAC FAILURE CONGESTIVE 88 0.0011
606 PAIN IN JAW 31 0.0011
607 MUSCULAR WEAKNESS 124 0.0011
608 EMPHYSEMA 11 0.0011
609 PROSTATIC SPECIFIC ANTIGEN INCREASED 15 0.0011
610 PRODUCT ADMINISTRATION ERROR 22 0.0011
611 THERAPEUTIC RESPONSE DECREASED 66 0.0011
612 HIP FRACTURE 35 0.0011
613 DYSURIA 40 0.0011
614 NERVE COMPRESSION 10 0.0011
615 FATIGUE 841 0.0011
616 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
617 WHITE BLOOD CELL COUNT DECREASED 117 0.0011
618 HYPOMAGNESAEMIA 15 0.0011
619 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
620 APHONIA 15 0.0011
621 HEAD DISCOMFORT 19 0.0011
622 INITIAL INSOMNIA 11 0.0011
623 LIVER FUNCTION TEST INCREASED 23 0.0011
624 CHOLELITHIASIS 35 0.0011
625 DEEP VEIN THROMBOSIS 69 0.0011
626 PALPITATIONS 124 0.0011
627 MUSCLE SPASTICITY 13 0.0011
628 UPPER LIMB FRACTURE 21 0.0011
629 SUBDURAL HAEMATOMA 15 0.0010
630 BLOOD POTASSIUM INCREASED 17 0.0010
631 DRUG DISPENSING ERROR 16 0.0010
632 INJECTION SITE SWELLING 80 0.0010
633 FULL BLOOD COUNT DECREASED 21 0.0010
634 PANCYTOPENIA 58 0.0010
635 MENTAL DISORDER 45 0.0010
636 CATARACT 61 0.0010
637 CYTOMEGALOVIRUS INFECTION 17 0.0010
638 PAIN IN EXTREMITY 301 0.0010
639 THERAPY INTERRUPTED 73 0.0010
640 HEPATIC STEATOSIS 19 0.0010
641 THINKING ABNORMAL 19 0.0010
642 MUSCLE SPASMS 187 0.0010
643 BALANCE DISORDER 88 0.0010
644 PERITONITIS 21 0.0010
645 URINARY INCONTINENCE 30 0.0010
646 MEMORY IMPAIRMENT 139 0.0010
647 MUSCULOSKELETAL PAIN 53 0.0010
648 DYSPHAGIA 96 0.0010
649 ASTHENIA 380 0.0010
650 NASOPHARYNGITIS 186 0.0010
651 ORAL DISCOMFORT 14 0.0010
652 PULMONARY OEDEMA 45 0.0010
653 HYPOCALCAEMIA 19 0.0010
654 PRESCRIBED UNDERDOSE 20 0.0010
655 HYPOAESTHESIA 150 0.0010
656 BLOOD PRESSURE FLUCTUATION 24 0.0010
657 SALIVARY HYPERSECRETION 10 0.0010
658 PLATELET COUNT INCREASED 13 0.0010
659 JOINT SWELLING 120 0.0010
660 BLOOD PRESSURE DECREASED 66 0.0010
661 GAIT DISTURBANCE 190 0.0010
662 URTICARIA 166 0.0010
663 ABDOMINAL DISCOMFORT 166 0.0010
664 BLOOD COUNT ABNORMAL 15 0.0010
665 HOSPITALISATION 152 0.0010
666 SEIZURE 114 0.0010
667 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23 0.0010
668 DRY THROAT 10 0.0010
669 SWELLING FACE 64 0.0010
670 LABORATORY TEST ABNORMAL 29 0.0010
671 HERNIA 19 0.0010
672 INTESTINAL OBSTRUCTION 37 0.0010
673 MOTOR DYSFUNCTION 10 0.0010
674 FEELING COLD 27 0.0010
675 TEMPERATURE INTOLERANCE 10 0.0010
676 VISION BLURRED 133 0.0010
677 DYSPNOEA 548 0.0010
678 FEAR 26 0.0010
679 PRODUCT DISPENSING ERROR 21 0.0010
680 MICTURITION URGENCY 11 0.0010
681 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
682 AGEUSIA 24 0.0010
683 THERAPEUTIC RESPONSE UNEXPECTED 43 0.0010
684 PETECHIAE 10 0.0010
685 NEOPLASM 11 0.0010
686 DEAFNESS 25 0.0010
687 MELAENA 21 0.0010
688 INJURY 67 0.0010
689 WEIGHT INCREASED 213 0.0010
690 INJECTION SITE DISCOMFORT 10 0.0009
691 DRY MOUTH 77 0.0009
692 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
693 INJECTION SITE RASH 29 0.0009
694 POST PROCEDURAL HAEMORRHAGE 11 0.0009
695 THROMBOSIS 76 0.0009
696 ASPARTATE AMINOTRANSFERASE INCREASED 50 0.0009
697 FEEDING DISORDER 19 0.0009
698 TINNITUS 43 0.0009
699 LIP SWELLING 31 0.0009
700 UNRESPONSIVE TO STIMULI 24 0.0009
701 HYPOAESTHESIA ORAL 14 0.0009
702 CHEST PAIN 171 0.0009
703 CHOKING 18 0.0009
704 DISEASE PROGRESSION 109 0.0009
705 VISUAL IMPAIRMENT 114 0.0009
706 ASCITES 27 0.0009
707 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
708 THERAPY NON-RESPONDER 41 0.0009
709 MYALGIA 155 0.0009
710 DISABILITY 18 0.0009
711 ABDOMINAL DISTENSION 95 0.0009
712 GASTROINTESTINAL PAIN 10 0.0009
713 LYMPHOCYTE COUNT DECREASED 16 0.0009
714 ANAPHYLACTIC REACTION 50 0.0009
715 HYPOTENSION 181 0.0009
716 ADVERSE DRUG REACTION 81 0.0009
717 RENAL DISORDER 42 0.0009
718 PLATELET COUNT DECREASED 96 0.0009
719 ANOSMIA 13 0.0009
720 GASTROINTESTINAL HAEMORRHAGE 75 0.0009
721 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
722 JOINT RANGE OF MOTION DECREASED 12 0.0009
723 NO ADVERSE EVENT 162 0.0009
724 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
725 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
726 RETCHING 19 0.0009
727 HALLUCINATION 67 0.0009
728 INCORRECT DRUG ADMINISTRATION DURATION 25 0.0009
729 HYPERTENSION 188 0.0009
730 VERTIGO 54 0.0009
731 PNEUMOTHORAX 14 0.0009
732 EYE DISORDER 29 0.0009
733 CRYING 32 0.0009
734 INJECTION SITE DISCOLOURATION 11 0.0009
735 MYOCARDIAL ISCHAEMIA 10 0.0009
736 CHILLS 103 0.0009
737 ERUCTATION 17 0.0009
738 HYPOTHYROIDISM 28 0.0009
739 THROMBOCYTOPENIA 98 0.0009
740 ACCIDENTAL EXPOSURE TO PRODUCT 90 0.0009
741 ALOPECIA 171 0.0009
742 DIABETES MELLITUS 66 0.0009
743 ABDOMINAL PAIN UPPER 178 0.0009
744 HAEMOGLOBIN DECREASED 88 0.0009
745 DIZZINESS 427 0.0009
746 SPLENOMEGALY 10 0.0009
747 BONE PAIN 50 0.0009
748 SKIN REACTION 12 0.0009
749 GASTROINTESTINAL DISORDER 76 0.0008
750 VENTRICULAR TACHYCARDIA 14 0.0008
751 PHOTOSENSITIVITY REACTION 14 0.0008
752 DIALYSIS 12 0.0008
753 EXTRAPYRAMIDAL DISORDER 21 0.0008
754 GASTRIC ULCER 16 0.0008
755 BRONCHOSPASM 12 0.0008
756 HEART RATE IRREGULAR 19 0.0008
757 TREATMENT NONCOMPLIANCE 46 0.0008
758 CHEST DISCOMFORT 86 0.0008
759 TENDONITIS 13 0.0008
760 EJECTION FRACTION DECREASED 13 0.0008
761 ANKYLOSING SPONDYLITIS 11 0.0008
762 PRODUCT AVAILABILITY ISSUE 19 0.0008
763 SWOLLEN TONGUE 26 0.0008
764 TRANSIENT ISCHAEMIC ATTACK 28 0.0008
765 ARTHROPATHY 46 0.0008
766 HYPOKINESIA 12 0.0008
767 RENAL FAILURE ACUTE 35 0.0008
768 LYMPHADENOPATHY 29 0.0008
769 INSOMNIA 218 0.0008
770 HAEMATURIA 28 0.0008
771 HAEMATOMA 21 0.0008
772 HYPERCALCAEMIA 10 0.0008
773 HAIR COLOUR CHANGES 10 0.0008
774 BONE LOSS 12 0.0008
775 FEELING ABNORMAL 191 0.0008
776 HYPOACUSIS 34 0.0008
777 PARAESTHESIA 124 0.0008
778 INTENTIONAL PRODUCT USE ISSUE 69 0.0008
779 CARDIAC ARREST 65 0.0008
780 VOMITING 370 0.0008
781 GASTRIC DISORDER 27 0.0008
782 NEUTROPHIL COUNT DECREASED 32 0.0008
783 INCORRECT PRODUCT ADMINISTRATION DURATION 17 0.0008
784 BODY TEMPERATURE INCREASED 16 0.0008
785 FAECES DISCOLOURED 17 0.0008
786 PRODUCT PREPARATION ERROR 16 0.0008
787 LYMPHOMA 12 0.0008
788 LUNG INFECTION 12 0.0008
789 HOT FLUSH 58 0.0008
790 INJECTION SITE PAIN 236 0.0008
791 RHEUMATOID ARTHRITIS 87 0.0008
792 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
793 INTENTIONAL PRODUCT MISUSE 67 0.0008
794 HYPONATRAEMIA 43 0.0008
795 INJECTION SITE PRURITUS 51 0.0008
796 TREMOR 126 0.0008
797 INJECTION SITE ERYTHEMA 94 0.0008
798 BLOOD CHOLESTEROL INCREASED 35 0.0008
799 HAIR TEXTURE ABNORMAL 10 0.0007
800 ORTHOSTATIC HYPOTENSION 13 0.0007
801 FEMUR FRACTURE 23 0.0007
802 TYPE 2 DIABETES MELLITUS 25 0.0007
803 PANIC ATTACK 27 0.0007
804 MUSCLE TIGHTNESS 12 0.0007
805 HEART RATE DECREASED 26 0.0007
806 SYNCOPE 74 0.0007
807 ACNE 56 0.0007
808 HYPERSENSITIVITY 137 0.0007
809 PANCREATITIS 39 0.0007
810 BRADYCARDIA 39 0.0007
811 SOMNOLENCE 148 0.0007
812 DRUG ERUPTION 13 0.0007
813 OSTEONECROSIS 24 0.0007
814 CORONARY ARTERY OCCLUSION 10 0.0007
815 PERIPHERAL COLDNESS 10 0.0007
816 TREATMENT FAILURE 60 0.0007
817 DYSARTHRIA 27 0.0007
818 PHARYNGEAL OEDEMA 11 0.0007
819 LUNG DISORDER 35 0.0007
820 EMOTIONAL DISORDER 22 0.0007
821 KNEE ARTHROPLASTY 15 0.0007
822 ACUTE MYOCARDIAL INFARCTION 21 0.0007
823 ABDOMINAL PAIN LOWER 18 0.0007
824 MOBILITY DECREASED 51 0.0007
825 DELUSION 11 0.0007
826 BLOOD BILIRUBIN INCREASED 19 0.0007
827 CARDIAC FAILURE 56 0.0007
828 MOOD ALTERED 19 0.0007
829 MIDDLE INSOMNIA 13 0.0007
830 APHASIA 21 0.0007
831 LOSS OF CONSCIOUSNESS 89 0.0007
832 MULTI-ORGAN FAILURE 12 0.0007
833 MUSCLE TWITCHING 16 0.0007
834 DRUG INTOLERANCE 67 0.0007
835 DIPLOPIA 18 0.0007
836 INJECTION SITE URTICARIA 17 0.0007
837 HYPERHIDROSIS 89 0.0007
838 C-REACTIVE PROTEIN INCREASED 25 0.0007
839 FRACTURE 13 0.0007
840 TACHYCARDIA 61 0.0007
841 MUSCULOSKELETAL STIFFNESS 60 0.0007
842 NEUTROPENIA 93 0.0007
843 MUSCULOSKELETAL DISORDER 13 0.0007
844 THERAPY CESSATION 35 0.0007
845 GLOSSODYNIA 15 0.0007
846 HAEMORRHAGE 70 0.0007
847 SPEECH DISORDER 35 0.0007
848 CARDIAC DISORDER 62 0.0007
849 PALLOR 18 0.0007
850 AMNESIA 43 0.0007
851 PRESYNCOPE 16 0.0007
852 ANGER 22 0.0006
853 THYROID DISORDER 10 0.0006
854 SKIN BURNING SENSATION 46 0.0006
855 INJECTION SITE REACTION 44 0.0006
856 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
857 BLINDNESS UNILATERAL 9 0.0006
858 CONFUSIONAL STATE 103 0.0006
859 FEELING HOT 39 0.0006
860 PRODUCT USE COMPLAINT 10 0.0006
861 ARRHYTHMIA 30 0.0006
862 PULMONARY EMBOLISM 60 0.0006
863 HYPERGLYCAEMIA 23 0.0006
864 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
865 HALLUCINATION, AUDITORY 10 0.0006
866 ANGINA PECTORIS 18 0.0006
867 INJECTION SITE BRUISING 50 0.0006
868 BLOOD GLUCOSE DECREASED 30 0.0006
869 PANCREATITIS ACUTE 14 0.0006
870 INJECTION SITE MASS 23 0.0006
871 DYSGEUSIA 46 0.0006
872 HALLUCINATION, VISUAL 13 0.0006
873 PLASMA CELL MYELOMA 24 0.0006
874 SHOCK 14 0.0006
875 DEMENTIA 17 0.0006
876 PERICARDIAL EFFUSION 14 0.0006
877 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
878 COGNITIVE DISORDER 28 0.0006
879 HAEMATEMESIS 15 0.0006
880 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
881 THROAT TIGHTNESS 16 0.0006
882 PNEUMONITIS 16 0.0006
883 CIRCULATORY COLLAPSE 10 0.0006
884 DEPRESSED MOOD 31 0.0006
885 HEPATIC CIRRHOSIS 11 0.0006
886 STEVENS-JOHNSON SYNDROME 13 0.0006
887 ACUTE MYELOID LEUKAEMIA 9 0.0006
888 FEELING JITTERY 11 0.0006
889 URINARY RETENTION 19 0.0006
890 SUICIDAL IDEATION 52 0.0006
891 COLD SWEAT 10 0.0006
892 METABOLIC ACIDOSIS 18 0.0006
893 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
894 MOVEMENT DISORDER 18 0.0006
895 INFLUENZA LIKE ILLNESS 46 0.0006
896 PRURITUS GENERALISED 12 0.0006
897 GLYCOSYLATED HAEMOGLOBIN INCREASED 14 0.0006
898 DRUG EFFECT INCOMPLETE 20 0.0006
899 DRUG RESISTANCE 14 0.0005
900 ILL-DEFINED DISORDER 33 0.0005
901 MOOD SWINGS 17 0.0005
902 IRRITABILITY 32 0.0005
903 DEATH 456 0.0005
904 NEOPLASM MALIGNANT 35 0.0005
905 INCREASED APPETITE 10 0.0005
906 DRUG INTERACTION 83 0.0005
907 ADVERSE EVENT 48 0.0005
908 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 37 0.0005
909 DISTURBANCE IN ATTENTION 28 0.0005
910 DYSKINESIA 21 0.0005
911 CARDIOVASCULAR DISORDER 13 0.0005
912 PSYCHOTIC DISORDER 15 0.0005
913 ABNORMAL DREAMS 14 0.0005
914 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
915 CEREBROVASCULAR ACCIDENT 85 0.0005
916 MENTAL IMPAIRMENT 12 0.0005
917 DEVICE BREAKAGE 20 0.0005
918 LIVER INJURY 12 0.0005
919 MALIGNANT NEOPLASM PROGRESSION 50 0.0005
920 INJECTION SITE WARMTH 10 0.0005
921 HEPATIC ENZYME INCREASED 33 0.0005
922 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 98 0.0005
923 NERVOUSNESS 25 0.0005
924 CARDIO-RESPIRATORY ARREST 20 0.0005
925 MYELOSUPPRESSION 17 0.0005
926 HEPATITIS 12 0.0005
927 NIGHTMARE 16 0.0005
928 RASH MACULO-PAPULAR 10 0.0004
929 AGITATION 33 0.0004
930 NERVOUS SYSTEM DISORDER 14 0.0004
931 NEEDLE ISSUE 13 0.0004
932 BLOOD GLUCOSE INCREASED 84 0.0004
933 MULTIPLE SCLEROSIS 21 0.0004
934 RESTLESSNESS 16 0.0004
935 HYPOGLYCAEMIA 21 0.0004
936 FLUSHING 44 0.0004
937 ERECTILE DYSFUNCTION 11 0.0004
938 DRUG ADMINISTRATION ERROR 13 0.0004
939 LEUKOPENIA 21 0.0004
940 DEVICE ISSUE 37 0.0004
941 LIVER DISORDER 18 0.0004
942 DISORIENTATION 16 0.0004
943 DELIRIUM 14 0.0004
944 NEOPLASM PROGRESSION 14 0.0004
945 RESPIRATORY ARREST 11 0.0004
946 GENERAL PHYSICAL HEALTH DETERIORATION 46 0.0004
947 EXTRA DOSE ADMINISTERED 16 0.0004
948 BLINDNESS 16 0.0004
949 VISUAL ACUITY REDUCED 13 0.0004
950 CEREBRAL HAEMORRHAGE 14 0.0004
951 INCORRECT DOSE ADMINISTERED 88 0.0004
952 WITHDRAWAL SYNDROME 16 0.0004
953 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
954 DRUG DOSE OMISSION 61 0.0004
955 VAGINAL HAEMORRHAGE 16 0.0004
956 DEVICE DISLOCATION 16 0.0004
957 ANGIOEDEMA 16 0.0004
958 MATERNAL EXPOSURE DURING PREGNANCY 32 0.0004
959 MYOCARDIAL INFARCTION 61 0.0003
960 DEVICE LEAKAGE 15 0.0003
961 LIVER FUNCTION TEST ABNORMAL 10 0.0003
962 PRODUCT STORAGE ERROR 30 0.0003
963 UNDERDOSE 25 0.0003
964 INTERSTITIAL LUNG DISEASE 16 0.0003
965 ABNORMAL BEHAVIOUR 13 0.0003
966 ACCIDENTAL OVERDOSE 12 0.0003
967 LUNG NEOPLASM MALIGNANT 13 0.0003
968 INJECTION SITE HAEMORRHAGE 24 0.0003
969 RHABDOMYOLYSIS 12 0.0003
970 PRODUCT QUALITY ISSUE 39 0.0003
971 DRUG DEPENDENCE 46 0.0003
972 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
973 ABORTION SPONTANEOUS 11 0.0003
974 SUICIDE ATTEMPT 16 0.0003
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 12 0.0003
976 DEVICE MALFUNCTION 18 0.0003
977 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
978 OVERDOSE 54 0.0003
979 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
980 PRODUCT SUBSTITUTION ISSUE 14 0.0002
981 EXPOSURE DURING PREGNANCY 15 0.0002
982 MEDICATION ERROR 13 0.0002
983 DISEASE RECURRENCE 11 0.0002
984 DRUG WITHDRAWAL SYNDROME 20 0.0002
985 AGGRESSION 11 0.0002
986 DRUG EFFECT DECREASED 11 0.0002
987 CONVULSION 11 0.0002
988 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
989 TOXICITY TO VARIOUS AGENTS 24 0.0001
990 BREAST CANCER 10 0.0001